[go: up one dir, main page]

WO2002008421A1 - Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide - Google Patents

Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide Download PDF

Info

Publication number
WO2002008421A1
WO2002008421A1 PCT/CN2001/001078 CN0101078W WO0208421A1 WO 2002008421 A1 WO2002008421 A1 WO 2002008421A1 CN 0101078 W CN0101078 W CN 0101078W WO 0208421 A1 WO0208421 A1 WO 0208421A1
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
necrosis factor
factor receptor
tumor necrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/001078
Other languages
English (en)
Chinese (zh)
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU2002210318A priority Critical patent/AU2002210318A1/en
Publication of WO2002008421A1 publication Critical patent/WO2002008421A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne un nouveau polypeptide, un récepteur humain 21.45 du facteur de la nécrose tumorale, et un polynucléotide codant ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de diverses tumeurs et de maladies dues à des inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant la récepteur humain 21.45 du facteur de la nécrose tumorale.
PCT/CN2001/001078 2000-06-30 2001-06-29 Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide Ceased WO2002008421A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002210318A AU2002210318A1 (en) 2000-06-30 2001-06-29 A novel polypeptide, a human tumor necrosis factor receptor 21.45 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00116922.X 2000-06-30
CN 00116922 CN1331208A (zh) 2000-06-30 2000-06-30 一种新的多肽——人肿瘤坏死因子受体21.45和编码这种多肽的多核苷酸

Publications (1)

Publication Number Publication Date
WO2002008421A1 true WO2002008421A1 (fr) 2002-01-31

Family

ID=4586321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/001078 Ceased WO2002008421A1 (fr) 2000-06-30 2001-06-29 Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide

Country Status (3)

Country Link
CN (1) CN1331208A (fr)
AU (1) AU2002210318A1 (fr)
WO (1) WO2002008421A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3346995B1 (fr) 2015-11-09 2019-08-28 Gilead Sciences, Inc. Compositions thérapeutiques pour le traitement du virus de l'immunodéficience humaine

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 12 December 1999 (1999-12-12), accession no. EMBL Database accession no. AL023577 *
DATABASE GENBANK [online] 12 December 1999 (1999-12-12), accession no. EMBL Database accession no. AL031588 *
DATABASE GENBANK [online] 14 December 1999 (1999-12-14), accession no. EMBL Database accession no. AL022325 *
DATABASE GENBANK [online] 17 November 1994 (1994-11-17), Database accession no. U14571 *
DATABASE GENBANK [online] 29 January 1998 (1998-01-29), Database accession no. AC002418 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3346995B1 (fr) 2015-11-09 2019-08-28 Gilead Sciences, Inc. Compositions thérapeutiques pour le traitement du virus de l'immunodéficience humaine

Also Published As

Publication number Publication date
AU2002210318A1 (en) 2002-02-05
CN1331208A (zh) 2002-01-16

Similar Documents

Publication Publication Date Title
WO2002008421A1 (fr) Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide
WO2002000822A3 (fr) Nouveau polypeptide, sous-unite humaine 2 $g(b) 16.5 du facteur d'initiation necessaire a la synthese proteique, et polynucleotide codant ce polypeptide
WO2001096526A3 (fr) Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide
WO2002000826A3 (fr) Nouveau polypeptide, proteine humaine de methylation d'adn, et polynucleotide codant ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2002000824A3 (fr) Nouveau polypeptide, proteine humaine 10.56 du gene cancerigene tre, et polynucleotide codant ce polypeptide
WO2001075054A3 (fr) Nouveau polypeptide, facteur humain de regulation 30 de la transcription de la microglobuline, et polynucleotide codant pour ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide
WO2001079439A3 (fr) Nouveau polypeptide, proteine humaine de reception cannabinoide 19, et un polynucleotide codant pour ce polypeptide
WO2001075023A3 (fr) Nouveau polypeptide, phosphatidylinositol-3 (ptdins 3) kinase humaine 9, et polynucleotide codant pour ce polypeptide
WO2001081534A3 (fr) Nouveau polypeptide, oxydoreductase 2fe-2s humaine 12, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001075020A3 (fr) Nouveau polypeptide, neuroproteine humaine y 11, et polynucleotide codant pour ce polypeptide
WO2001075062A3 (fr) Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075056A3 (fr) Nouveau polypeptide, clathrine humaine a chaine legere 20, et polynucleotide codant pour ce polypeptide
WO2001096524A3 (fr) Nouveau polypeptide, recepteur humain sigma 10.67, et polynucleotide codant ce polypeptide
WO2001075018A3 (fr) Nouveau polypeptide, facteur humain de regulation de la transcription 31, et polynucleotide codant pour ce polypeptide
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide
WO2001075048A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide
WO2001075058A3 (fr) Nouveau polypeptide, aminoacyl-arnt synthetase humaine 15 de type ii, et polynucleotide codant pour ce polypeptide
WO2001075029A3 (fr) Nouveau polypeptide, facteur humain 11 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2001075024A3 (fr) Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2001075043A3 (fr) Nouveau polypeptide, proteine kinase humaine 9 adn-dependante, et polynucleotide codant pour ce polypeptide
WO2001083685A3 (fr) Nouveau polypeptide, proteine cap 10, et polynucleotide codant pour ce polypeptide
WO2001075025A3 (fr) Nouveau polypeptide, thyroglobuline humaine 9, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP